Joint (JYNT) Competitors $11.15 +0.18 (+1.64%) (As of 01:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends JYNT vs. FSNB, ORC, GAMI, CTO, ALTI, FPI, VINP, GMRE, CHCT, and PKSTShould you be buying Joint stock or one of its competitors? The main competitors of Joint include Fusion Acquisition Corp. II (FSNB), Orchid Island Capital (ORC), GAMCO Investors (GAMI), CTO Realty Growth (CTO), AlTi Global (ALTI), Farmland Partners (FPI), Vinci Partners Investments (VINP), Global Medical REIT (GMRE), Community Healthcare Trust (CHCT), and Peakstone Realty Trust (PKST). These companies are all part of the "trading" industry. Joint vs. Fusion Acquisition Corp. II Orchid Island Capital GAMCO Investors CTO Realty Growth AlTi Global Farmland Partners Vinci Partners Investments Global Medical REIT Community Healthcare Trust Peakstone Realty Trust Joint (NASDAQ:JYNT) and Fusion Acquisition Corp. II (NYSE:FSNB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends. Which has better earnings and valuation, JYNT or FSNB? Fusion Acquisition Corp. II has lower revenue, but higher earnings than Joint. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJoint$120.80M1.36-$9.75M-$1.14-9.62Fusion Acquisition Corp. IIN/AN/A$16.57MN/AN/A Which has more risk & volatility, JYNT or FSNB? Joint has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500. Comparatively, Fusion Acquisition Corp. II has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Is JYNT or FSNB more profitable? Fusion Acquisition Corp. II has a net margin of 0.00% compared to Joint's net margin of -13.95%. Joint's return on equity of 8.24% beat Fusion Acquisition Corp. II's return on equity.Company Net Margins Return on Equity Return on Assets Joint-13.95% 8.24% 2.33% Fusion Acquisition Corp. II N/A N/A N/A Do analysts recommend JYNT or FSNB? Joint currently has a consensus target price of $17.50, indicating a potential upside of 59.53%. Given Joint's stronger consensus rating and higher possible upside, research analysts clearly believe Joint is more favorable than Fusion Acquisition Corp. II.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Joint 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Fusion Acquisition Corp. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to JYNT or FSNB? In the previous week, Joint had 1 more articles in the media than Fusion Acquisition Corp. II. MarketBeat recorded 1 mentions for Joint and 0 mentions for Fusion Acquisition Corp. II. Joint's average media sentiment score of 1.26 beat Fusion Acquisition Corp. II's score of 0.00 indicating that Joint is being referred to more favorably in the media. Company Overall Sentiment Joint Positive Fusion Acquisition Corp. II Neutral Do institutionals & insiders have more ownership in JYNT or FSNB? 76.9% of Joint shares are owned by institutional investors. 30.2% of Joint shares are owned by insiders. Comparatively, 73.6% of Fusion Acquisition Corp. II shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community prefer JYNT or FSNB? Joint received 282 more outperform votes than Fusion Acquisition Corp. II when rated by MarketBeat users. CompanyUnderperformOutperformJointOutperform Votes28262.53% Underperform Votes16937.47% Fusion Acquisition Corp. IIN/AN/A SummaryJoint beats Fusion Acquisition Corp. II on 11 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024‘Gift’ Yourself a Potential 10,000% Win! #1 Crypto to Buy Before 2025 REVEALED! Click here to get all the details on this crypto coin now. Get Joint News Delivered to You Automatically Sign up to receive the latest news and ratings for JYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JYNT vs. The Competition Export to ExcelMetricJointPatent owners & lessors IndustryMedical SectorNASDAQ ExchangeMarket Cap$164.37M$1.13B$5.14B$9.31BDividend YieldN/A6.78%4.81%4.06%P/E Ratio-9.625.84135.3117.54Price / Sales1.36258.261,260.42139.42Price / Cash16.0112.7740.5837.95Price / Book6.533.474.884.92Net Income-$9.75M-$3.05M$118.89M$225.78M7 Day Performance-5.59%-1.86%15.96%-1.56%1 Month Performance1.57%-1.70%15.87%6.68%1 Year Performance20.15%3.63%34.78%22.48% Joint Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JYNTJoint3.7443 of 5 stars$11.15+1.6%$17.50+57.0%+18.1%$167.07M$120.80M-9.78444Positive NewsFSNBFusion Acquisition Corp. IIN/A$10.49-0.2%N/AN/A$655.63MN/A0.002ORCOrchid Island Capital4.0583 of 5 stars$8.12+1.0%$9.50+17.0%-4.8%$648.38M$75.70M7.662,018Positive NewsGAMIGAMCO InvestorsN/A$26.31flatN/A+27.9%$638.25M$235.87M10.12177News CoverageCTOCTO Realty Growth2.7972 of 5 stars$20.60+2.3%$21.00+1.9%+19.2%$617.51M$118.66M34.1430ALTIAlTi Global2.3239 of 5 stars$4.34-4.4%$9.00+107.4%-46.8%$606.85M$246.97M-2.59430News CoveragePositive NewsFPIFarmland Partners1.596 of 5 stars$12.40-1.9%$15.00+21.0%-2.6%$597.35M$58.34M45.1425Dividend IncreasePositive NewsVINPVinci Partners Investments4.3248 of 5 stars$10.68-0.1%$13.50+26.4%+0.8%$574.37M$91.03M17.24240GMREGlobal Medical REIT4.213 of 5 stars$8.43-0.4%$11.25+33.5%-23.5%$563.12M$141.05M-423.2930News CoverageCHCTCommunity Healthcare Trust2.7743 of 5 stars$18.47+2.1%$21.00+13.7%-28.0%$521.63M$115.61M-201.0037Analyst ForecastPositive NewsPKSTPeakstone Realty Trust1.7859 of 5 stars$13.35+8.4%$15.00+12.4%-33.5%$485.67M$254.28M-11.2035News CoveragePositive News Related Companies and Tools Related Companies Fusion Acquisition Corp. II Competitors Orchid Island Capital Competitors GAMCO Investors Competitors CTO Realty Growth Competitors AlTi Global Competitors Farmland Partners Competitors Vinci Partners Investments Competitors Global Medical REIT Competitors Community Healthcare Trust Competitors Peakstone Realty Trust Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:JYNT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Joint With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
